Victory Capital Management
TVTX icon

Victory Capital Management’s Travere Therapeutics TVTX Stock Holding History

Victory Capital Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Sell
33,370
-78,263
-70% -$3.47M ﹤0.01% 1647
2026
Q1 		$3.32M Buy
111,633
+71,884
+181% +$2.15M ﹤0.01% 1462
2025
Q4 		$1.52M Sell
39,749
-5,786
-13% -$188K ﹤0.01% 1651
2025
Q3 		$1.09M Buy
45,535
+20,886
+85% +$393K ﹤0.01% 1798
2025
Q2 		$365K Buy
24,649
+14,108
+134% +$234K ﹤0.01% 2112
2025
Q1 		$189K Buy
10,541
+78
+0.7% +$1.58K ﹤0.01% 2234
2024
Q4 		$182K Buy
+10,463
New +$185K ﹤0.01% 2256
2022
Q4 		– Sell
-17,547
Closed -$432K – 2707
2022
Q3 		$432K Sell
17,547
-1,092
-6% -$28.2K ﹤0.01% 2111
2022
Q2 		$452K Buy
18,639
+480
+3% +$12.1K ﹤0.01% 2100
2022
Q1 		$456K Buy
18,159
+10,410
+134% +$276K ﹤0.01% 2158
2021
Q4 		$241K Buy
+7,749
New +$218K ﹤0.01% 2437
2021
Q2 		– Sell
-8,608
Closed -$215K – 2812
2021
Q1 		$215K Buy
+8,608
New +$238K ﹤0.01% 2510
2020
Q2 		– Sell
-5,004
Closed -$73K – 3234
2020
Q1 		$73K Buy
+5,004
New +$75.3K ﹤0.01% 2408
2019
Q4 		– Sell
-5,149
Closed -$60K – 3241
2019
Q3 		$60K Buy
+5,149
New +$85.1K ﹤0.01% 2607

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's TVTX Position: Q2 2026 in Review

Victory Capital Management reduced its Travere Therapeutics (TVTX) stake by 70% in Q2 2026, selling an estimated $3.47M and leaving 33,370 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Victory Capital Management first reported a position in TVTX in Q3 2019 and has held it in 14 quarters since. The position peaked at $3.32M in Q1 2026. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Victory Capital Management held 33,370 shares of Travere Therapeutics worth $1.9M as of Q2 2026.
  • Victory Capital Management sold 78,263 Travere Therapeutics shares in Q2 2026, an estimated $3.47M.
  • Travere Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1647 holding.
  • Victory Capital Management first reported a position in Travere Therapeutics in Q3 2019 and has held it in 14 quarters since.
  • Victory Capital Management's Travere Therapeutics position peaked at $3.32M in Q1 2026.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.